"In 2014, with nothing more than safety studies (Phase 1) started in melanoma, BioNTech struck numerous deals through 2014 - 2018:
“Strategic collaborations across the pipeline (Bayer Animal Health, Genentech, a member of the Roche Group, Genmab, Siemens, Sanofi, Regeneron, Genevant, Pfizer, University of Pennsylvania)”
Excuse me, why would all these companies do business with BioNTech—they had nothing of proven value, diddly squat, in the pipeline. In normal times, going to these companies with just two safety studies in the bag would be a certain route out the door onto the pavement (sidewalk for our US colleagues)."
Then suddenly, in 2020, BioNTech buys a large manufacturing plant in Marburg from Novartis."
For those still not knowing what this is all about, it is based on the fact that No Clinical Trial data has been published for the Process 2 jabs manufactured using E. coli, resulting in Endotoxin that can't be removed by any process used by Pfizer or Moderna. The trial results submitted for Emergency Use Authorization were based on Process 1 producing highly purified DNA generated by RT-PCR of computer code ordered mRNA, then used to make more mRNA for the vials.
Andrew Bridgen has an advance copy of my book chapter commissioned by AMPS
Great post Geoff! This may add further info. on BioNTech: https://open.substack.com/pub/hedleyrees/p/biontechthe-virtual-company-with?r=xoehy&utm_campaign=post&utm_medium=web
"In 2014, with nothing more than safety studies (Phase 1) started in melanoma, BioNTech struck numerous deals through 2014 - 2018:
“Strategic collaborations across the pipeline (Bayer Animal Health, Genentech, a member of the Roche Group, Genmab, Siemens, Sanofi, Regeneron, Genevant, Pfizer, University of Pennsylvania)”
Excuse me, why would all these companies do business with BioNTech—they had nothing of proven value, diddly squat, in the pipeline. In normal times, going to these companies with just two safety studies in the bag would be a certain route out the door onto the pavement (sidewalk for our US colleagues)."
Then suddenly, in 2020, BioNTech buys a large manufacturing plant in Marburg from Novartis."
For those still not knowing what this is all about, it is based on the fact that No Clinical Trial data has been published for the Process 2 jabs manufactured using E. coli, resulting in Endotoxin that can't be removed by any process used by Pfizer or Moderna. The trial results submitted for Emergency Use Authorization were based on Process 1 producing highly purified DNA generated by RT-PCR of computer code ordered mRNA, then used to make more mRNA for the vials.
Andrew Bridgen has an advance copy of my book chapter commissioned by AMPS
https://geoffpain.substack.com/p/production-of-the-pfizer-biontech